Companies: 10,795·Total market cap: $144.5T

Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc.

AUPHNASDAQHealthcare● Active

$15.84

$-0.53(-3.24%)

Market Cap$2.0B

P/E Ratio—

52W High$16.88

52W Low$7.285

Avg Volume1.2M

Open$16.44

Beta1.43

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Aurinia Pharmaceuticals Inc.（AUPH）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · AUPH · 截至 Jun 8, 2026

关键指标

EPS (TTM)—Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)—Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding—Shares outstanding history

Next EarningsTBAEarnings history

探索 Aurinia Pharmaceuticals Inc. 数据

分析师预测—

股息不分红

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Aurinia Pharmaceuticals Inc.

$15.84-3.24%$2.0B #2

AbCellera Biologics Inc.

$5.62-11.77%$1.7B #3

$10.80-5.26%$1.1B #4

Celldex Therapeutics, Inc.

$28.62-4.38%$1.9B #5

Harmony Biosciences Holdings, Inc.

$32.20-2.31%$1.9B #6

Immunocore Holdings plc

$28.29-1.63%$1.4B

关于 Aurinia Pharmaceuticals Inc.

CEOKevin C. Tang

IPO DateSep 3, 2014

Employees130

CountryCA

Websiteauriniapharma.com

Aurinia Pharmaceuticals Inc. a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States a…

Biotechnology HealthcareNASDAQCA

关于股票概览与关键数据

Aurinia Pharmaceuticals Inc.（AUPH）是 Biotechnology 行业的 Healthcare 类公司，于 Sep 3, 2014 在 NASDAQ 上市。截至最近交易日，AUPH 股价为 $15.84，市值约为 $2.0B。过去12个月累计回报 —，年初至今回报 —。

常见问题

截至最近一个交易日，Aurinia Pharmaceuticals Inc.（AUPH）股价为 $15.84，在 NASDAQ 上市，52周区间为 $7.29 – $16.88。

AUPH 最新股价AUPH quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议